Zeria Pharmaceutical Co., Ltd.

TSE:4559.T

2375 (JPY) • At close November 5, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) JPY.

2024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q42015 Q32015 Q22015 Q12014 Q42014 Q32014 Q22014 Q12013 Q42013 Q32013 Q22013 Q12012 Q42012 Q32012 Q22012 Q12011 Q42011 Q32011 Q22011 Q12010 Q42010 Q32010 Q22010 Q12009 Q42009 Q32009 Q22009 Q12008 Q42008 Q32008 Q2
Revenue 21,45517,805.87921,240.79218,373.87318,304.53116,653.48918,017.25817,407.29716,305.18314,428.05616,498.615,057.21113,548.96213,068.77615,557.10613,472.05313,333.7914,141.56615,976.84715,205.81615,111.00114,622.64116,722.58915,222.24215,256.28814,950.94617,224.31216,432.77315,969.66815,838.61416,712.20815,821.21216,488.14715,439.5216,698.65815,612.20414,728.64815,296.31315,624.86615,412.1514,727.62515,262.88816,630.81714,759.87815,338.29813,042.57214,349.87813,063.86912,868.66512,008.89714,601.49613,119.1513,464.94411,782.47812,954.57513,067.31211,709.99812,797.72513,693.10312,651.99311,618.98711,940.8811,589.94512,774.092
Cost of Revenue 5,4775,175.355,416.4515,058.1534,573.8044,414.1925,103.7134,824.1944,552.5284,104.9114,816.9424,212.7214,250.0033,880.2544,267.7293,772.6923,876.2043,888.3134,199.4034,286.7074,269.194,320.064,605.0164,459.5134,368.0664,251.6764,628.0064,700.8614,761.3474,646.4414,659.9794,578.8214,283.744,399.3664,616.0594,277.3654,637.5924,598.8044,492.6624,600.8214,828.8474,869.8944,684.2694,631.1114,162.3964,082.4024,414.6984,483.1424,616.3674,360.7794,817.6444,491.3234,877.7774,258.2534,904.174,574.9974,704.8796,012.5435,999.7915,867.9895,420.4315,870.7885,275.8686,025.085
Gross Profit 15,97812,630.52915,824.34113,315.7213,730.72712,239.29712,913.54512,583.10311,752.65510,323.14511,681.65810,844.499,298.9599,188.52211,289.3779,699.3619,457.58610,253.25311,777.44410,919.10910,841.81110,302.58112,117.57310,762.72910,888.22210,699.2712,596.30611,731.91211,208.32111,192.17312,052.22911,242.39112,204.40711,040.15412,082.59911,334.83910,091.05610,697.50911,132.20410,811.3299,898.77810,392.99411,946.54810,128.76711,175.9028,960.179,935.188,580.7278,252.2987,648.1189,783.8528,627.8278,587.1677,524.2258,050.4058,492.3157,005.1196,785.1827,693.3126,784.0046,198.5566,070.0926,314.0776,749.007
Gross Profit Ratio 0.7450.7090.7450.7250.750.7350.7170.7230.7210.7150.7080.720.6860.7030.7260.720.7090.7250.7370.7180.7170.7050.7250.7070.7140.7160.7310.7140.7020.7070.7210.7110.740.7150.7240.7260.6850.6990.7120.7010.6720.6810.7180.6860.7290.6870.6920.6570.6410.6370.670.6580.6380.6390.6210.650.5980.530.5620.5360.5330.5080.5450.528
Reseach & Development Expenses 01,049.9199318558919698808527554,7898662,0309565,4110006,3420006,8320007,3310008,4580008,5790009,8820007,4640005,629000000000000000000
General & Administrative Expenses 06,157.6320006,427.0250001,118000-1,156000-2,679000-3,040000-2,694000-3,688000-3,410000-3,418000-2,915000-1,215000000000000000000
Selling & Marketing Expenses 05,2900004,3790003,5460005,3480005,8790005,8350005,8200005,5220005,0980004,8950005,0200003,418000000000000000000
SG&A 12,03911,447.63210,726.87410,103.44510,76010,806.0259,377.5228,813.5548,7754,6648,8599,4237,091.1564,1929,0319,1618,3973,20010,13510,5929,5122,79511,12610,3269,2553,12610,4029,93510,6111,83411,5599,81510,4831,68810,40410,2489,0631,47710,0729,3909,0402,10510,0428,9218,3222,2038,3837,5480000000000000000
Other Expenses 099.965-85.34420.602134.139-16.2875.726.60125.749-10.24-4.5050.87619.4544.041-31.78233.65432.73930.2316.6557.237-7.179-36.5434.87124.63336.25511.99115.73310.82431.437-24.566.084-3.42429.73750.9114.9898.95521.3929.6417.95.14232.963-36.21216.78111.07325.03-61.383-122.1334.255227.931-19.173112.285-80.701170.3472.67369.325-44.937173.246-11.0860.769-21.154146.7075.8555.422-9.908
Operating Expenses 10,68212,497.55111,661.04810,958.44510,760.56211,775.02510,257.5229,665.5548,775.5259,452.8198,858.459,423.7678,047.1569,603.4079,0319,160.8288,397.5339,541.17210,133.69210,509.8579,512.0729,626.57211,125.98610,326.1359,255.34410,456.48310,402.2629,935.36510,611.29910,291.92211,559.5599,814.55310,483.58310,267.21210,404.16110,248.1469,063.37311,359.14610,071.1869,390.2419,040.5769,568.79110,041.5598,921.6628,322.1187,831.588,382.7437,547.9617,354.8437,760.4527,791.0357,347.9787,178.7336,957.8877,151.4717,002.3276,652.6086,612.3897,237.1996,002.7516,027.3295,831.036,195.8386,023.368
Operating Income 3,939132.9784,163.2932,357.2742,970.165464.2722,656.0232,917.5492,977.129870.3262,823.2071,420.7231,251.802-414.8862,258.377538.5341,060.051712.0831,643.751409.2521,329.738676.009991.588436.5931,632.877242.7872,194.0431,796.547597.022900.25492.6711,427.8381,720.823772.9421,678.4391,086.6921,027.682-661.6371,061.0181,421.088858.201824.2041,904.9891,207.1052,853.7821,128.5891,552.4371,032.766897.455-112.3341,992.8171,279.8491,408.434566.338898.9341,489.988352.511172.793456.113781.253171.227239.062118.239725.639
Operating Income Ratio 0.1840.0070.1960.1280.1620.0280.1470.1680.1830.060.1710.0940.092-0.0320.1450.040.080.050.1030.0270.0880.0460.0590.0290.1070.0160.1270.1090.0370.0570.0290.090.1040.050.1010.070.07-0.0430.0680.0920.0580.0540.1150.0820.1860.0870.1080.0790.07-0.0090.1360.0980.1050.0480.0690.1140.030.0140.0330.0620.0150.020.010.057
Total Other Income Expenses Net 1,521-820.083-380.727699.94238568.859-887.25-918.927-6-776-314-386831.238-252.647353.059131.049249.366101.949-164.695-338.484226.683140.071-82.139-264.561,690.574-242.579243.129117.17629.151-253.932484.114-179.069328.138-354.547564.166-86.321573.007-130.52341.1574.58856.06-191.224-60.04618.247752.25268.10589.094815.419440.041105.71462.147-195.107139.729-468.225-43.847-89.28156.565107.215-160.587-121.034161.586268.98414.995194.527
Income Before Tax 5,460-687.1053,782.5663,057.2163,355.717533.1311,768.7731,998.6222,972.17294.5022,507.6841,036.5372,083.041-667.5322,611.436669.5821,309.419814.031,479.05770.7681,556.422816.08909.448172.0343,323.4520.2082,437.1731,913.7171,226.173646.319976.7841,248.7692,048.962418.3952,242.6041,000.3721,600.69-792.1571,402.1681,495.6681,714.262632.9791,844.9431,225.3523,606.0361,196.6951,641.5311,848.1851,337.496-6.622,054.9641,084.7421,548.16398.113855.0871,400.707409.076280.008295.526660.219332.813508.046133.234920.166
Income Before Tax Ratio 0.254-0.0390.1780.1660.1830.0320.0980.1150.1820.0070.1520.0690.154-0.0510.1680.050.0980.0580.0930.0050.1030.0560.0540.0110.21800.1410.1160.0770.0410.0580.0790.1240.0270.1340.0640.109-0.0520.090.0970.1160.0410.1110.0830.2350.0920.1140.1410.104-0.0010.1410.0830.1150.0080.0660.1070.0350.0220.0220.0520.0290.0430.0110.072
Income Tax Expense 1,22255.566752.557563.139441.923323.03-221.157596.489367.525168.234579.781327.63671.324-111.622313.605253.353336.073220.018366.432-13.578408.595260.373287.462133.7971,075.576-208.825602.432437.591563.047-28.716104.526556.68712.463226.567518.983275.447708.794-189.643357.703428.672665.563-73.019610.341325.0921,172.476491.704573.415512.169449.07344.874858.498345.436516.232-3.42313.184419.677199.22930.919121.285258.989155.59517139.435368.085
Net Income 4,212-692.073,026.5552,481.3562,915.42215.0221,982.2631,397.2912,601.289-82.4051,927.597707.0361,408.956-566.4352,297.603414.454974.163585.4641,109.54884.1021,146.261553.107620.46936.1642,244.358202.71,826.7921,470.72657.598670.652866.863678.3421,328.502178.2851,718.391724.925891.895-602.5141,044.4661,066.9951,048.699705.9981,234.602900.8632,435.617704.4411,058.9381,329.301889.546-66.5461,177.107720.2941,030.162109.916541.902981.029209.847249.089174.24401.229177.217337.04693.798552.081
Net Income Ratio 0.196-0.0390.1420.1350.1590.0130.110.080.16-0.0060.1170.0470.104-0.0430.1480.0310.0730.0410.0690.0060.0760.0380.0370.0020.1470.0140.1060.0890.0410.0420.0520.0430.0810.0120.1030.0460.061-0.0390.0670.0690.0710.0460.0740.0610.1590.0540.0740.1020.069-0.0060.0810.0550.0770.0090.0420.0750.0180.0190.0130.0320.0150.0280.0080.043
EPS 95.55-15.768.6656.2966.144.8844.9131.6558.71-1.8442.6815.7430.91-12.4350.48.9621.0212.6523.981.7724.1411.6513.070.7244.594.0336.327.712.3912.6316.3312.7725.013.3632.3513.6516.79-11.3419.6620.0919.7413.2923.2419.8153.5615.4923.2929.2319.56-1.4625.8815.8422.652.4211.9121.564.615.473.838.823.897.41.7710.39
EPS Diluted 95.55-15.768.6656.2966.144.8844.9131.6558.71-1.8442.6815.6830.91-12.4350.48.9621.0212.6523.981.7724.1411.6513.070.7244.594.0336.327.712.3912.6316.3312.7725.013.3632.3513.6516.79-11.3419.6620.0919.7413.2923.2419.8153.5615.4923.2929.2319.56-1.4625.8815.8422.652.4211.9121.564.615.473.838.823.897.41.7710.39
EBITDA 5,827.752,463.9064,069.2052,255.6043,466.444693.2831,859.9442,303.6523,059.851405.6132,580.241,113.9522,151.304-295.3092,283.348731.752693.416863.8241,513.34208.3411,607.665527.294956.402221.8331,790.014245.5082,410.971,924.171703.828995.674488.0371,319.0811,902.689764.5562,266.0891,066.177643.328-516.7121,142.1041,351.488998.933795.5581,907.7851,202.0753,141.3981,072.5451,725.5991,007.1731,158.885-151.72,102.641,107.9961,653.4791,322.9371,613.4182,055.6831,219.922884.0931,095.0891,343.428887.065828.047731.336725.493
EBITDA Ratio 0.2720.1380.1920.1230.1890.0420.1030.1320.1880.0280.1560.0740.159-0.0230.1470.0540.0520.0610.0950.0140.1060.0360.0570.0150.1170.0160.140.1170.0440.0630.0290.0830.1150.050.1360.0680.044-0.0340.0730.0880.0680.0520.1150.0810.2050.0820.120.0770.09-0.0130.1440.0840.1230.1120.1250.1570.1040.0690.080.1060.0760.0690.0630.057